Frequently Asked Questions
The market is segmented based on , By Product Type (Magnetic Resonance Imaging Scanners, Computed Tomography Scanners, Position Emission Tomography Scanners, Biosimilar (EEG), Electromyography Devices (EMG), Magnetoencphalography Devices, Transcranial Doppler Devices, Intracranial Pressure Monitors (ICP), Electrodes, Sensors, Gels and Cables), Drug Class (Insulin, Recombinant Human Growth Hormone (RHGH), Granulocyte Colony-Stimulating Factor, Interferon, Erythropoietin, Etanercept, Monoclonal Antibodies, Follitropin, Glucagon, Calcitonin, Teriparatide, Enoxaparin Sodium), Type of Manufacturing (In-House Manufacturing and Contract Manufacturing), Procedure (Invasive and Non-Invasive), Disease (Stroke, Dementia and Epilepsy), Indication (Atrial Septal Defect (ASD), Ventricular Septal Defect (VSD), Patent Foramen Ovale (PFO), Aortic Valve Stenosis and Others), Therapy Type (Oncology, Immunology, Haematology, Hormone Therapy, Metabolic Disorders, and Others), End Users (Hospitals, Clinics, Diagnostic Centres and Others) – Industry Trends and Forecast to 2030.
.
The Global Biosimilar Market size was valued at USD 37270.20 USD Million in 2022.
The Global Biosimilar Market is projected to grow at a CAGR of 32% during the forecast period of 2023 to 2030.
The major players operating in the market include Novartis AG, Orion Pharma AB, Pfizer , Samsung Bioepis, Coherus BioSciences , Amgen , Eli Lilly and Company, Takeda Pharmaceutical Company Limited, Bristol-Myers Squibb Company, Merck KGaA, Teva Pharmaceutical Industries Ltd, Biocon, Bayer AG, AbbVie , Allergan, Dr. Reddy’s Laboratories Ltd, Boehringer Ingelheim International GmbH, Biogen,.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
